Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reichen

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Molecular Immunology|December 14, 2001
Perspectives: towards a peptide-based vaccine against hepatitis C virusI P Hunziker, R Zurbriggen, R Glueck, et al.
The Clinical Investigator|November 1, 1993
Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trialJ Reichen, M Solioz, H Bühler, et al.
The Journal of Experimental Medicine|August 4, 1999
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognitionA R Kammer, S H van der Burg, B Grabscheid, et al.
Cellular Immunology|September 28, 2000
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infectionM Cucchiarini, A R Kammer, B Grabscheid, et al.
Journal of Hepatology|September 1, 1996
Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the LiverJ Reichen, L Bianchi, H Bühler, et al.
Journal of Hepatology|February 2, 1999
Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosisP Lahaye, L Fouassier, K A Tazi, et al.
The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem, S V Feinman, J Rasenack, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Molecular Immunology|December 14, 2001
Perspectives: towards a peptide-based vaccine against hepatitis C virusI P Hunziker, R Zurbriggen, R Glueck, et al.
The Clinical Investigator|November 1, 1993
Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trialJ Reichen, M Solioz, H Bühler, et al.
The Journal of Experimental Medicine|August 4, 1999
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognitionA R Kammer, S H van der Burg, B Grabscheid, et al.
Cellular Immunology|September 28, 2000
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infectionM Cucchiarini, A R Kammer, B Grabscheid, et al.
Journal of Hepatology|September 1, 1996
Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the LiverJ Reichen, L Bianchi, H Bühler, et al.
Journal of Hepatology|February 2, 1999
Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosisP Lahaye, L Fouassier, K A Tazi, et al.
The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem, S V Feinman, J Rasenack, et al.
Pageof 19